Investors
Patients
Press
Chercher dans le site
Select your language
FR
Expanded Access Policy
Company
About the Company
Team
Partners
Careers
Expertise
Therapeutic Strategy
Research & Development
Publication
Pipeline
News
Contact
[EN] Secondary Menu
Investors
Patients
Press
Chercher dans le site
Select your language
FR
[ALL] Réseaux sociaux
News
Alzprotect announces the WHO approval of generic name Ezeprogind for the « first-in-Class » AZP2006 clinical stage drug
Read more …
Brand identity: Alzprotect changes its signature
Read more …
Interview Biotech Finances
Interview Biotech Finances 25/06/2020
Read more …
Alzprotect obtains authorization to start a Phase 2a clinical trial in PSP
Read more …
Page 3 of 3
1
2
3
